Penbutolol
Penbutolol has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 26, 2021: “Identification and drug-induced reversion of molecular signatures of Alzheimer's disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse models”.
See all 1 papers on penbutolol
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya and 7 more
- Animals1
What did studies of penbutolol find?
1Studies of penbutolol measured one outcome, cognitive impairment.
Cognitive impairment
downin mice1
1 study
Cognitive impairment
downin mice1
Penbutolol decreases cognitive impairment in AD mice.
“two NSAIDs (dexketoprofen and etodolac) and two anti-hypertensives (penbutolol and bendroflumethiazide) that overturn the cognitive impairment in AD mice”
Animalsin AD micehippocampus
Genome medicine